# Study of S1B-408 in Women With Orgasmic Dysfunction

> **NCT06516055** · PHASE2 · NOT_YET_RECRUITING · sponsor: **S1 Biopharma, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Orgasmic Disorder

## Interventions

- **DRUG:** S1B-408

## Key facts

- **NCT ID:** NCT06516055
- **Lead sponsor:** S1 Biopharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06516055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06516055, "Study of S1B-408 in Women With Orgasmic Dysfunction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06516055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*